Dyskeratosis Congenita Medication

Updated: Jan 27, 2020
  • Author: David T Robles, MD, PhD, FAAD; Chief Editor: William D James, MD  more...
  • Print

Medication Summary

The goals of pharmacotherapy are to reduce morbidity and to prevent complications.


Colony-stimulating factors

Class Summary

These agents are used to stimulate bone marrow in patients with cytopenia of one or more cell lineage.

Erythropoietin (Epogen, Procrit)

Erythropoietin stimulates division and differentiation of erythroid progenitor cells.

Filgrastim (Neupogen)

Filgrastim activates and stimulates production, maturation, migration, and cytotoxicity of neutrophils.